rs115283528

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002354.3(EPCAM):​c.831A>G​(p.Ile277Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00165 in 1,613,570 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I277V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0015 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 7 hom. )

Consequence

EPCAM
NM_002354.3 missense

Scores

3
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.08

Publications

11 publications found
Variant links:
Genes affected
EPCAM (HGNC:11529): (epithelial cell adhesion molecule) This gene encodes a carcinoma-associated antigen and is a member of a family that includes at least two type I membrane proteins. This antigen is expressed on most normal epithelial cells and gastrointestinal carcinomas and functions as a homotypic calcium-independent cell adhesion molecule. The antigen is being used as a target for immunotherapy treatment of human carcinomas. Mutations in this gene result in congenital tufting enteropathy. [provided by RefSeq, Dec 2008]
EPCAM Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Lynch syndrome 8
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • congenital diarrhea 5 with tufting enteropathy
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet, G2P, Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00895828).
BP6
Variant 2-47379942-A-G is Benign according to our data. Variant chr2-47379942-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 127851.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00146 (222/152316) while in subpopulation SAS AF = 0.00228 (11/4828). AF 95% confidence interval is 0.00128. There are 0 homozygotes in GnomAd4. There are 117 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 7 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EPCAMNM_002354.3 linkc.831A>G p.Ile277Met missense_variant Exon 7 of 9 ENST00000263735.9 NP_002345.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EPCAMENST00000263735.9 linkc.831A>G p.Ile277Met missense_variant Exon 7 of 9 1 NM_002354.3 ENSP00000263735.4
EPCAMENST00000405271.5 linkc.915A>G p.Ile305Met missense_variant Exon 8 of 10 5 ENSP00000385476.1
EPCAMENST00000456133.5 linkn.915A>G non_coding_transcript_exon_variant Exon 8 of 11 5 ENSP00000410675.1
EPCAMENST00000490733.1 linkn.680A>G non_coding_transcript_exon_variant Exon 5 of 6 3

Frequencies

GnomAD3 genomes
AF:
0.00147
AC:
223
AN:
152198
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000410
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00893
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.00188
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.00151
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.00217
AC:
543
AN:
249802
AF XY:
0.00230
show subpopulations
Gnomad AFR exome
AF:
0.000805
Gnomad AMR exome
AF:
0.00163
Gnomad ASJ exome
AF:
0.00806
Gnomad EAS exome
AF:
0.0000547
Gnomad FIN exome
AF:
0.00255
Gnomad NFE exome
AF:
0.00210
Gnomad OTH exome
AF:
0.00295
GnomAD4 exome
AF:
0.00167
AC:
2439
AN:
1461254
Hom.:
7
Cov.:
32
AF XY:
0.00177
AC XY:
1289
AN XY:
726894
show subpopulations
African (AFR)
AF:
0.000837
AC:
28
AN:
33454
American (AMR)
AF:
0.00184
AC:
82
AN:
44652
Ashkenazi Jewish (ASJ)
AF:
0.00869
AC:
227
AN:
26128
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39680
South Asian (SAS)
AF:
0.00311
AC:
268
AN:
86208
European-Finnish (FIN)
AF:
0.00210
AC:
112
AN:
53390
Middle Eastern (MID)
AF:
0.0203
AC:
117
AN:
5768
European-Non Finnish (NFE)
AF:
0.00128
AC:
1427
AN:
1111614
Other (OTH)
AF:
0.00293
AC:
177
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
153
305
458
610
763
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00146
AC:
222
AN:
152316
Hom.:
0
Cov.:
32
AF XY:
0.00157
AC XY:
117
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.000409
AC:
17
AN:
41562
American (AMR)
AF:
0.00131
AC:
20
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00893
AC:
31
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4828
European-Finnish (FIN)
AF:
0.00188
AC:
20
AN:
10618
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.00151
AC:
103
AN:
68040
Other (OTH)
AF:
0.00331
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
12
24
35
47
59
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00191
Hom.:
0
Bravo
AF:
0.00146
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.00221
AC:
19
ExAC
AF:
0.00206
AC:
250
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

EPCAM: BP4 -

May 03, 2020
Genomic Research Center, Shahid Beheshti University of Medical Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 03, 2021
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 20, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Dec 12, 2013
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jul 26, 2021
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

EPCAM-related disorder Benign:1
Jan 10, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Hereditary cancer-predisposing syndrome Benign:1
Apr 30, 2018
True Health Diagnostics
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
15
DANN
Uncertain
0.98
DEOGEN2
Benign
0.044
T;T
Eigen
Benign
-0.38
Eigen_PC
Benign
-0.41
FATHMM_MKL
Benign
0.73
D
LIST_S2
Benign
0.83
.;T
M_CAP
Benign
0.033
D
MetaRNN
Benign
0.0090
T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
1.9
.;L
PhyloP100
1.1
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.59
N;N
REVEL
Benign
0.13
Sift
Uncertain
0.017
D;D
Sift4G
Uncertain
0.0080
D;D
Polyphen
0.74
P;P
Vest4
0.41
MVP
0.61
MPC
0.023
ClinPred
0.033
T
GERP RS
-0.51
Varity_R
0.045
gMVP
0.31
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115283528; hg19: chr2-47607081; API